BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18784435)

  • 1. Molecular profiling of isolated histological components of wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development.
    Maschietto M; de Camargo B; Brentani H; Grundy P; Sredni ST; Torres C; Mota LD; Cunha IW; Patrão DF; Costa CM; Soares FA; Brentani RR; Carraro DM
    Oncology; 2008; 75(1-2):81-91. PubMed ID: 18784435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.
    Maschietto M; Trapé AP; Piccoli FS; Ricca TI; Dias AA; Coudry RA; Galante PA; Torres C; Fahhan L; Lourenço S; Grundy PE; de Camargo B; de Souza S; Neves EJ; Soares FA; Brentani H; Carraro DM
    Cell Death Dis; 2011 Nov; 2(11):e224. PubMed ID: 22048167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney.
    Dekel B; Metsuyanim S; Schmidt-Ott KM; Fridman E; Jacob-Hirsch J; Simon A; Pinthus J; Mor Y; Barasch J; Amariglio N; Reisner Y; Kaminski N; Rechavi G
    Cancer Res; 2006 Jun; 66(12):6040-9. PubMed ID: 16778176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.
    Schweigert A; Fischer C; Mayr D; von Schweinitz D; Kappler R; Hubertus J
    Pediatr Surg Int; 2016 Dec; 32(12):1141-1146. PubMed ID: 27679509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target.
    Pode-Shakked N; Harari-Steinberg O; Haberman-Ziv Y; Rom-Gross E; Bahar S; Omer D; Metsuyanim S; Buzhor E; Jacob-Hirsch J; Goldstein RS; Mark-Danieli M; Dekel B
    Oncogene; 2011 Apr; 30(14):1664-80. PubMed ID: 21472018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
    Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
    Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour.
    Maschietto M; Piccoli FS; Costa CM; Camargo LP; Neves JI; Grundy PE; Brentani H; Soares FA; Camargo Bd; Carraro DM
    Eur J Cancer; 2011 Dec; 47(18):2715-22. PubMed ID: 21703850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in situ hybridization analysis of PAX2, PAX8, and WT1 gene transcription in human fetal kidney and Wilms' tumors.
    Eccles MR; Yun K; Reeve AE; Fidler AE
    Am J Pathol; 1995 Jan; 146(1):40-5. PubMed ID: 7856737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
    Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
    J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development.
    Zirn B; Wittmann S; Graf N; Gessler M
    Cancer Lett; 2005 Mar; 220(1):115-20. PubMed ID: 15737694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition.
    Li CM; Guo M; Borczuk A; Powell CA; Wei M; Thaker HM; Friedman R; Klein U; Tycko B
    Am J Pathol; 2002 Jun; 160(6):2181-90. PubMed ID: 12057921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
    Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
    Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors.
    Koesters R; Ridder R; Kopp-Schneider A; Betts D; Adams V; Niggli F; Briner J; von Knebel Doeberitz M
    Cancer Res; 1999 Aug; 59(16):3880-2. PubMed ID: 10463574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canonical WNT signalling determines lineage specificity in Wilms tumour.
    Fukuzawa R; Anaka MR; Weeks RJ; Morison IM; Reeve AE
    Oncogene; 2009 Feb; 28(8):1063-75. PubMed ID: 19137020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms tumor--a renal stem cell malignancy?
    Pode-Shakked N; Dekel B
    Pediatr Nephrol; 2011 Sep; 26(9):1535-43. PubMed ID: 21499773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?
    Corbin M; de Reyniès A; Rickman DS; Berrebi D; Boccon-Gibod L; Cohen-Gogo S; Fabre M; Jaubert F; Faussillon M; Yilmaz F; Sarnacki S; Landman-Parker J; Patte C; Schleiermacher G; Antignac C; Jeanpierre C
    Genes Chromosomes Cancer; 2009 Sep; 48(9):816-27. PubMed ID: 19530245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.
    Zirn B; Samans B; Spangenberg C; Graf N; Eilers M; Gessler M
    Oncogene; 2005 Aug; 24(33):5246-51. PubMed ID: 15897880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor.
    Sehic D; Karlsson J; Sandstedt B; Gisselsson D
    Pediatr Blood Cancer; 2012 Jul; 59(1):62-8. PubMed ID: 22180226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters.
    Zirn B; Hartmann O; Samans B; Krause M; Wittmann S; Mertens F; Graf N; Eilers M; Gessler M
    Int J Cancer; 2006 Apr; 118(8):1954-62. PubMed ID: 16287080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.